Welocalize Launches Dedicated Life Sciences Division
Frederick, MD, January 31, 2017 (Newswire.com) - Welocalize, global leader in innovative translation and localization solutions, announces the formation of Welocalize Life Sciences, a division that brings together the recent Welocalize acquisitions of Global Language Solutions (GLS) and Nova Language Services (Nova). The merged entities represent more than two decades of experience in specialized language services for clinical research, biotechnology, healthcare, medical devices, pharmaceutical companies and animal health.
"Translation and localization play a vital role in clinical trials, patient recruitment and regulatory affairs material and documentation," said Erin Wynn, chief customer officer and head of regulated industries at Welocalize. "Welocalize Life Sciences has an established network of subject matter experts with a track record of more than 20-years proven success in ensuring translations are accurate and submission-ready. Our success is derived from partnering with global brands and institutions in life sciences and regulated industries to reduce time-to-market and effectively communicate with their communities and patients in more than 175 global languages."
Welocalize is focused on helping our clients with inclusive and wide-ranging language solutions across their entire life sciences global journey, from product creation and patent translation to patient recruitment and testing, as well as localization for market launch, sales and marketing.
Smith Yewell, CEO and co-founder of Welocalize
Welocalize Life Sciences is the convergence GLS and Nova, which were both acquired in 2016 by Welocalize. GLS and Nova each have decades of established experience in delivering language services to their extensive client portfolios of life sciences companies. The combined teams into a single organization, Welocalize Life Sciences, will continue to service these and new clients under the Welocalize Life Sciences brand.
"Welocalize is focused on helping our clients with inclusive and wide-ranging language solutions across their entire life sciences global journey, from product creation and patent translation to patient recruitment and testing, as well as localization for market launch, sales and marketing," said Smith Yewell, CEO and co-founder of Welocalize.
The combined entities of these acquisitions under a single brand, Welocalize Life Sciences, follows a successful integration of two industry leaders in life science localization and translation services into the Welocalize brand family. The combination leverages more than 20 plus years of exceptional talent, quality management, language experience and outstanding customer service dedicated to pharma, biotech, med devices, clinical research, healthcare and animal health.
For more information about Welocalize Life Sciences, visit its website lifesciences.welocalize.com.
Welocalize Life Sciences provides specialized language solutions for highly regulated industries. Our solutions include industry expert localization and translation services for regulatory and compliance content, document translation, linguistic validation, interpreting, website and marketing localization, eLearning and multimedia services. Welocalize Life Sciences is an industry leader with proven translation and localization proficiency required for global clinical trials, pharmaceuticals, biotech companies, medical devices, healthcare brands, medical providers and government agencies. Welocalize is ISO 9001:2015, ISO 17100 and ISO 13845 certified. lifesciences.welocalize.com @Welocalize_LS
About Welocalize, Inc.
Welocalize, Inc., founded in 1997, offers innovative language services to help global brands reach audiences around the world in more than 175 languages. We provide translation and localization services, talent management, language tools, automation and technology, quality and program management. Our range of managed language services includes machine translation, digital marketing, validation and testing, interpretation, staffing and enterprise translation management technologies. We specialize in consumer, technology, manufacturing, learning, oil and gas, travel and hospitality, marketing and advertising, finance, legal and life sciences industry language solutions. With more than 1,000 full-time employees worldwide, Welocalize maintains offices in the United States, United Kingdom, Germany, Ireland, Spain, Italy, Romania, Poland, Japan and China. www.welocalize.com @Welocalize
Source: Welocalize Life Sciences
Share:
Tags: biotech, clinical research, clinical trials, global trials, healthcare, interpretation, interpreting, language services, localization, pharma, translate, translation